> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Alliance Advocates for Increased FDA Funding
- URL: https://www.fdaweb.com/fda-alliance-advocates-for-increased-fda-funding/
- Published: 2019-11-07T12:00:00.000Z
- Updated: 2026-09-14T15:52:19.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145448

The Alliance for a Stronger FDA is advocating for increased FDA funding in fiscal year 2020 because “growing responsibilities require a budget that grows.” That was the message during an 11/6 Webinar from Alliance deputy executive director **Steven Grossman** as he discussed FDA’s positioning in the current funding cycle.

Currently in the FY 2020 budget process, the House has passed a $3.25 billion budget for FDA, which is $185 million (6%) more than FY 2019 appropriated levels, according to Grossman. On the Senate side, the appropriations committee just last month passed a $3.15 billion spending level that would give the agency $79 million (about 3%) more than last year, he said. At some point, the disparities in the spending measures will be rectified in a conference committee.

Going forward, Grossman does not expect any budget deals being reached before the current operating continuing resolution (CR) expires 11/21, and so another temporary CR will be approved through 12/21\. Grossman also said it is likely that the current budget stalemate will carryover until early next year.

Addressing a question on whether the federal government may experience another shutdown like last year at this time, Grossman said it would be unlikely because unlike a year ago defense spending is unresolved and “in play” this time around. For example, he said a government shutdown this cycle could see 800,000 civilian employees furloughed. The politics of a shutdown or even a move to funding through a full-year continuing resolution is just not there, he said.

If the budget bills stall and the government gets funding through a full-year continuing resolution, then that would be bad news for FDA because it would lose the $79 million to $185 million increases that the House and Senate chambers have proposed to date, Grossman said.